Prasol Chemicals Limited reported a 151% year-on-year increase in net profit for the first quarter of fiscal year 2027, reaching ₹610 million. The significant rise in bottom line was supported by robust top-line growth and improved operational efficiency.

Revenue for the quarter stood at ₹4.3 billion, marking a 34% increase from the ₹3.2 billion recorded in the corresponding period last year. This expansion in sales volume directly contributed to the enhanced profitability metrics observed during the period.

Profitability and Margins

The company's EBITDA surged to ₹904 million, more than doubling the ₹407 million reported in the same quarter last year. This substantial growth in operating earnings led to a notable expansion in margins.

IPO Completion and Board Updates

Subsequent to the quarter ended June 30, 2026, the company completed its Initial Public Offer (IPO) of 7,396,437 equity shares at an issue price of ₹676 per share, aggregating to ₹5,000 million. The shares were listed on NSE and BSE on September 16, 2026. The issue comprised an offer for sale of ₹4,200 million and a fresh issue of ₹800 million.

The Board of Directors also noted the retirement of Dr. Chitra Vaidya, Vice-President – R&D, effective from the close of business hours on September 30, 2026. Additionally, the board approved the unaudited financial results for the quarter ended June 30, 2026, which were reviewed by statutory auditors CNK & Associates LLP.

What the Numbers Show

A key observation from the data is the disproportionate growth in profitability relative to revenue. While revenue grew by 34%, EBITDA expanded by approximately 122%, and net profit rose by 151%. This divergence indicates strong operating leverage, where incremental revenue translated into significantly higher profits due to cost efficiencies or better product mix, as evidenced by the EBITDA margin jumping from 12.74% to 20.85%.

Prasol Chemicals has highlighted two core product segments, acetone-based and phosphorus-based specialty chemicals, as its primary revenue contributors, with acetone accounting for 43% and phosphorus-based products at 38% of revenue.

Revenue composition by product segment

The company's revenue mix reflects a clear concentration in two chemical categories. Together, acetone and phosphorus-based specialty chemicals represent the dominant share of Prasol Chemicals' topline, as outlined below.

Acetone-based chemicals lead the revenue mix at 43%, while phosphorus-based specialty chemicals contribute 38%, making these two segments collectively central to the company's business profile.